1. Home
  2. LBRDK vs PTCT Comparison

LBRDK vs PTCT Comparison

Compare LBRDK & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LBRDK

Liberty Broadband Corporation Class C

N/A

Current Price

$35.93

Market Cap

4.8B

ML Signal

N/A

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.10

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDK
PTCT
Founded
2014
1998
Country
United States
United States
Employees
1900
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.7B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
LBRDK
PTCT
Price
$35.93
$69.10
Analyst Decision
Buy
Analyst Count
0
17
Target Price
N/A
$80.65
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
264.48
EPS
N/A
0.90
Revenue
N/A
$264,734,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$109.28
$17.70
P/E Ratio
$10.10
$76.78
Revenue Growth
N/A
36.19
52 Week Low
$26.25
$43.18
52 Week High
$65.73
$90.87

Technical Indicators

Market Signals
Indicator
LBRDK
PTCT
Relative Strength Index (RSI) 64.47 31.40
Support Level $29.37 $68.16
Resistance Level $39.60 $72.09
Average True Range (ATR) 1.65 3.14
MACD 0.67 -1.37
Stochastic Oscillator 98.52 28.34

Price Performance

Historical Comparison
LBRDK
PTCT

About LBRDK Liberty Broadband Corporation Class C

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: